Drug Type ASO |
Synonyms- |
Target |
Mechanism KRAS G12V inhibitors(GTPase KRas G12V inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization Molecular AxiomStartup |
Active Organization Molecular AxiomStartup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Lung Cancer | Preclinical | - | Molecular AxiomStartup | 02 Mar 2023 |